MedTrace Logo

Wearable Assessments in the Clinic and Home in PD

NCT03681015 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2024-10-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate disease progression in persons with early Parkinson disease, as assessed by digital and electronic sensor data collection to be correlated with typical clinical assessments.

Conditions

  • Parkinson Disease

Sponsors & Collaborators

  • Biogen

    collaborator INDUSTRY

  • Takeda

    collaborator INDUSTRY

  • University of Rochester

    lead OTHER

Principal Investigators

  • Earl R Dorsey, MD MBA · University of Rochester

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-24
Primary Completion
2022-02-21
Completion
2022-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03681015 on ClinicalTrials.gov